Blood Pressure Medications - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Blood Pressure Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Blood Pressure Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Blood Pressure Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report studies and analyses global Blood Pressure Medications status and future trends, helps the client to determine the Blood Pressure Medications market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Blood Pressure Medications, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Blood Pressure Medications market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Blood Pressure Medications sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Blood Pressure Medications sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Blood Pressure Medications key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Blood Pressure Medications key producing regions, capacity, production, and year over year growth
(6) Blood Pressure Medications industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Medicine
Market segment by Type, covers
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Compound Drugs
Diuretics
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Blood Pressure Medications product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Blood Pressure Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Blood Pressure Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Blood Pressure Medications, percent & CAGR, 2018-2029
Chapter 5: Blood Pressure Medications industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Blood Pressure Medications Definition
1.2 Global Blood Pressure Medications Market Size and Forecast
1.2.1 By Consumption Value, Global Blood Pressure Medications Market Size，2018-2029
1.2.2 By Sales Quantity, Global Blood Pressure Medications Market Size，2018-2029
1.2.3 Global Blood Pressure Medications Average Selling Price (ASP)，2018-2029
1.3 China Blood Pressure Medications Market Size and Forecast
1.3.1 By Consumption Value, China Blood Pressure Medications Market Size，2018-2029
1.3.2 By Sales Quantity, China Blood Pressure Medications Market Size，2018-2029
1.3.3 China Blood Pressure Medications Average Selling Price (ASP)， 2018-2029
1.4 Share of China Blood Pressure Medications Market with Respect to the Global Market
1.4.1 By Consumption Value, China Blood Pressure Medications Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Blood Pressure Medications Market Share in Global, 2018-2029
1.4.3 Blood Pressure Medications Market Size: China VS Global, 2018-2029
1.5 Blood Pressure Medications Market Dynamics
1.5.1 Blood Pressure Medications Market Drivers
1.5.2 Blood Pressure Medications Market Restraints
1.5.3 Blood Pressure Medications Industry Trends
1.5.4 Blood Pressure Medications Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Blood Pressure Medications, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Blood Pressure Medications, Global Market Share by Company, 2018-2023
2.3 Blood Pressure Medications Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Blood Pressure Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Blood Pressure Medications Concentration Ratio
2.6 Global Blood Pressure Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Blood Pressure Medications Manufacturers Product Type
2.8 Head Office and Blood Pressure Medications Production Site of Key Manufacturer
2.9 Blood Pressure Medications Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Blood Pressure Medications, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Blood Pressure Medications, China Market Share by Company, 2018-2023
3.3 China Blood Pressure Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Blood Pressure Medications Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Blood Pressure Medications Capacity by Region
4.3 Global Blood Pressure Medications Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Blood Pressure Medications Production by Region, 2018-2029
4.5 Global Blood Pressure Medications Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Blood Pressure Medications Industry Chain
5.2 Blood Pressure Medications Upstream Analysis
5.2.1 Blood Pressure Medications Core Raw Materials
5.2.2 Main Manufacturers of Blood Pressure Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Blood Pressure Medications Production Mode
5.6 Blood Pressure Medications Procurement Model
5.7 Blood Pressure Medications Industry Sales Model and Sales Channels
5.7.1 Blood Pressure Medications Sales Model
5.7.2 Blood Pressure Medications Typical Distributors
6 Sights by Type
6.1 Blood Pressure Medications Classification
6.1.1 Calcium Channel Blockers
6.1.2 ACE Inhibitors
6.1.3 Angiotensin II Receptor Blockers
6.1.4 Beta Blockers
6.1.5 Compound Drugs
6.1.6 Diuretics
6.1.7 Others
6.2 By Type, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Blood Pressure Medications Consumption Value, 2018-2029
6.4 By Type, Global Blood Pressure Medications Sales Quantity, 2018-2029
6.5 By Type, Global Blood Pressure Medications Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Blood Pressure Medications Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Others
7.2 By Application, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Blood Pressure Medications Consumption Value, 2018-2029
7.4 By Application, Global Blood Pressure Medications Sales Quantity, 2018-2029
7.5 By Application, Global Blood Pressure Medications Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Blood Pressure Medications Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Blood Pressure Medications Consumption Value, 2018-2029
8.3 By Region, Global Blood Pressure Medications Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Blood Pressure Medications & Forecasts, 2018-2029
8.4.2 By Country, North America Blood Pressure Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Blood Pressure Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Blood Pressure Medications Market Size Market Share
8.7 South America
8.7.1 South America Blood Pressure Medications Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Blood Pressure Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Blood Pressure Medications Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Blood Pressure Medications Consumption Value, 2018-2029
9.3 By Country, Global Blood Pressure Medications Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Blood Pressure Medications Market Size, 2018-2029
9.4.2 By Type, U.S. Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Blood Pressure Medications Market Size, 2018-2029
9.5.2 By Type, Europe Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Blood Pressure Medications Market Size, 2018-2029
9.6.2 By Type, China Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Blood Pressure Medications Market Size, 2018-2029
9.7.2 By Type, Japan Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Blood Pressure Medications Market Size, 2018-2029
9.8.2 By Type, South Korea Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Blood Pressure Medications Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Blood Pressure Medications Market Size, 2018-2029
9.10.2 By Type, India Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Blood Pressure Medications Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Blood Pressure Medications Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer Blood Pressure Medications Models, Specifications, and Application
10.1.3 Pfizer Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Novartis
10.2.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novartis Blood Pressure Medications Models, Specifications, and Application
10.2.3 Novartis Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis Company Profile and Main Business
10.2.5 Novartis Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.3.2 AstraZeneca Blood Pressure Medications Models, Specifications, and Application
10.3.3 AstraZeneca Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AstraZeneca Company Profile and Main Business
10.3.5 AstraZeneca Recent Developments
10.4 Bayer
10.4.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bayer Blood Pressure Medications Models, Specifications, and Application
10.4.3 Bayer Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Bayer Company Profile and Main Business
10.4.5 Bayer Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.5.2 Sanofi Blood Pressure Medications Models, Specifications, and Application
10.5.3 Sanofi Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.6.2 Boehringer Ingelheim Blood Pressure Medications Models, Specifications, and Application
10.6.3 Boehringer Ingelheim Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Boehringer Ingelheim Company Profile and Main Business
10.6.5 Boehringer Ingelheim Recent Developments
10.7 Merck
10.7.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.7.2 Merck Blood Pressure Medications Models, Specifications, and Application
10.7.3 Merck Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Merck Company Profile and Main Business
10.7.5 Merck Recent Developments
10.8 Lupin Pharmaceuticals
10.8.1 Lupin Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.8.2 Lupin Pharmaceuticals Blood Pressure Medications Models, Specifications, and Application
10.8.3 Lupin Pharmaceuticals Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Lupin Pharmaceuticals Company Profile and Main Business
10.8.5 Lupin Pharmaceuticals Recent Developments
10.9 Huahai Pharmaceutical
10.9.1 Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Huahai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
10.9.3 Huahai Pharmaceutical Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Huahai Pharmaceutical Company Profile and Main Business
10.9.5 Huahai Pharmaceutical Recent Developments
10.10 Jiangsu Jibeier Pharmaceutical
10.10.1 Jiangsu Jibeier Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
10.10.3 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jiangsu Jibeier Pharmaceutical Company Profile and Main Business
10.10.5 Jiangsu Jibeier Pharmaceutical Recent Developments
10.11 Tianjin Pharmaceutical Da Ren Tang Group
10.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information, Head Office, Market Area, and Industry Position
10.11.2 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Models, Specifications, and Application
10.11.3 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Tianjin Pharmaceutical Da Ren Tang Group Company Profile and Main Business
10.11.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
10.12 Chengdu Easton Biopharmaceuticals
10.12.1 Chengdu Easton Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.12.2 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Models, Specifications, and Application
10.12.3 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Chengdu Easton Biopharmaceuticals Company Profile and Main Business
10.12.5 Chengdu Easton Biopharmaceuticals Recent Developments
10.13 Qingdao Huanghai Pharmaceutical
10.13.1 Qingdao Huanghai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
10.13.3 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Qingdao Huanghai Pharmaceutical Company Profile and Main Business
10.13.5 Qingdao Huanghai Pharmaceutical Recent Developments
10.14 CR Double-Crane
10.14.1 CR Double-Crane Company Information, Head Office, Market Area, and Industry Position
10.14.2 CR Double-Crane Blood Pressure Medications Models, Specifications, and Application
10.14.3 CR Double-Crane Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 CR Double-Crane Company Profile and Main Business
10.14.5 CR Double-Crane Recent Developments
10.15 Shanghai Shyndec Pharmaceutical
10.15.1 Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
10.15.3 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Shanghai Shyndec Pharmaceutical Company Profile and Main Business
10.15.5 Shanghai Shyndec Pharmaceutical Recent Developments
10.16 CSPC Pharmaceutical Group
10.16.1 CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
10.16.2 CSPC Pharmaceutical Group Blood Pressure Medications Models, Specifications, and Application
10.16.3 CSPC Pharmaceutical Group Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 CSPC Pharmaceutical Group Company Profile and Main Business
10.16.5 CSPC Pharmaceutical Group Recent Developments
10.17 Jiangsu Hengrui Medicine
10.17.1 Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
10.17.2 Jiangsu Hengrui Medicine Blood Pressure Medications Models, Specifications, and Application
10.17.3 Jiangsu Hengrui Medicine Blood Pressure Medications Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Jiangsu Hengrui Medicine Company Profile and Main Business
10.17.5 Jiangsu Hengrui Medicine Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Blood Pressure Medications Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Blood Pressure Medications Market Restraints
Table 3. Blood Pressure Medications Market Trends
Table 4. Blood Pressure Medications Industry Policy
Table 5. Global Blood Pressure Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Blood Pressure Medications Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Blood Pressure Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Blood Pressure Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Blood Pressure Medications Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Blood Pressure Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Blood Pressure Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Blood Pressure Medications Manufacturers Product Type
Table 13. Head Office and Blood Pressure Medications Production Site of Key Manufacturer
Table 14. Blood Pressure Medications Capacity of Major Manufacturers and Future Plan
Table 15. China Blood Pressure Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Blood Pressure Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Blood Pressure Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Blood Pressure Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Blood Pressure Medications Production by Region, 2018-2023, (K Units)
Table 20. Global Blood Pressure Medications Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Blood Pressure Medications Upstream (Raw Materials)
Table 22. Global Blood Pressure Medications Typical Customers
Table 23. Blood Pressure Medications Typical Distributors
Table 24. By Type, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Blood Pressure Medications Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Blood Pressure Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Blood Pressure Medications Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Blood Pressure Medications Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Blood Pressure Medications Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Blood Pressure Medications Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Blood Pressure Medications Models, Specifications, and Application
Table 36. Pfizer Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 40. Novartis Blood Pressure Medications Models, Specifications, and Application
Table 41. Novartis Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis Company Profile and Main Business
Table 43. Novartis Recent Developments
Table 44. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 45. AstraZeneca Blood Pressure Medications Models, Specifications, and Application
Table 46. AstraZeneca Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AstraZeneca Company Profile and Main Business
Table 48. AstraZeneca Recent Developments
Table 49. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 50. Bayer Blood Pressure Medications Models, Specifications, and Application
Table 51. Bayer Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bayer Company Profile and Main Business
Table 53. Bayer Recent Developments
Table 54. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 55. Sanofi Blood Pressure Medications Models, Specifications, and Application
Table 56. Sanofi Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Sanofi Company Profile and Main Business
Table 58. Sanofi Recent Developments
Table 59. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
Table 60. Boehringer Ingelheim Blood Pressure Medications Models, Specifications, and Application
Table 61. Boehringer Ingelheim Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Boehringer Ingelheim Company Profile and Main Business
Table 63. Boehringer Ingelheim Recent Developments
Table 64. Merck Company Information, Head Office, Market Area, and Industry Position
Table 65. Merck Blood Pressure Medications Models, Specifications, and Application
Table 66. Merck Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Merck Company Profile and Main Business
Table 68. Merck Recent Developments
Table 69. Lupin Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Lupin Pharmaceuticals Blood Pressure Medications Models, Specifications, and Application
Table 71. Lupin Pharmaceuticals Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Lupin Pharmaceuticals Company Profile and Main Business
Table 73. Lupin Pharmaceuticals Recent Developments
Table 74. Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Huahai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 76. Huahai Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Huahai Pharmaceutical Company Profile and Main Business
Table 78. Huahai Pharmaceutical Recent Developments
Table 79. Jiangsu Jibeier Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 80. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 81. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jiangsu Jibeier Pharmaceutical Company Profile and Main Business
Table 83. Jiangsu Jibeier Pharmaceutical Recent Developments
Table 84. Tianjin Pharmaceutical Da Ren Tang Group Company Information, Head Office, Market Area, and Industry Position
Table 85. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Models, Specifications, and Application
Table 86. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Tianjin Pharmaceutical Da Ren Tang Group Company Profile and Main Business
Table 88. Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
Table 89. Chengdu Easton Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 90. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Models, Specifications, and Application
Table 91. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Chengdu Easton Biopharmaceuticals Company Profile and Main Business
Table 93. Chengdu Easton Biopharmaceuticals Recent Developments
Table 94. Qingdao Huanghai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 96. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Qingdao Huanghai Pharmaceutical Company Profile and Main Business
Table 98. Qingdao Huanghai Pharmaceutical Recent Developments
Table 99. CR Double-Crane Company Information, Head Office, Market Area, and Industry Position
Table 100. CR Double-Crane Blood Pressure Medications Models, Specifications, and Application
Table 101. CR Double-Crane Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. CR Double-Crane Company Profile and Main Business
Table 103. CR Double-Crane Recent Developments
Table 104. Shanghai Shyndec Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Models, Specifications, and Application
Table 106. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Shanghai Shyndec Pharmaceutical Company Profile and Main Business
Table 108. Shanghai Shyndec Pharmaceutical Recent Developments
Table 109. CSPC Pharmaceutical Group Company Information, Head Office, Market Area, and Industry Position
Table 110. CSPC Pharmaceutical Group Blood Pressure Medications Models, Specifications, and Application
Table 111. CSPC Pharmaceutical Group Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. CSPC Pharmaceutical Group Company Profile and Main Business
Table 113. CSPC Pharmaceutical Group Recent Developments
Table 114. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
Table 115. Jiangsu Hengrui Medicine Blood Pressure Medications Models, Specifications, and Application
Table 116. Jiangsu Hengrui Medicine Blood Pressure Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Jiangsu Hengrui Medicine Company Profile and Main Business
Table 118. Jiangsu Hengrui Medicine Recent Developments
List of Figures
Figure 1. Blood Pressure Medications Picture
Figure 2. Global Blood Pressure Medications Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Blood Pressure Medications Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Blood Pressure Medications Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Blood Pressure Medications Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Blood Pressure Medications Sales Quantity (K Units) & (2018-2029)
Figure 7. China Blood Pressure Medications Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Blood Pressure Medications Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Blood Pressure Medications Market Share of Global, 2018-2029
Figure 10. Global Blood Pressure Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Blood Pressure Medications Key Participants, Market Share, 2022
Figure 12. Global Blood Pressure Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Blood Pressure Medications Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Blood Pressure Medications Production Market Share & Forecast by Region, 2018-2029
Figure 15. Blood Pressure Medications Industry Chain
Figure 16. Blood Pressure Medications Procurement Model
Figure 17. Blood Pressure Medications Sales Model
Figure 18. Blood Pressure Medications Sales Channels, Direct Sales, and Distribution
Figure 19. Calcium Channel Blockers
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|